AARDEX Group

reliable

In pursuit of better answers: WHO aims for higher quality clinical trial evidence with best-practice guidance

WHO cares​. It’s now time you did Why Change is Needed in Clinical Trials? The old adage tells us not to fix things that aren’t broken. Logic suggests, therefore, that whenever a fix is being applied, things aren’t working as … Read More

WHO Cares: A pro-adherence strategy means little without the drive for better data quality

Enhancing Adherence in Clinical Trials: A Strategic Imperative When a high-profile authority in the medical world, such as the World Health Organization (WHO), publishes guidelines on best practices in clinical trials, the industry takes note. Aiming for Reform and Improvement … Read More

Sealed envelopes: When are we going to properly address non-digital adherence measurement in clinical trials?

From Sealed Envelopes to Smart Adherence: Why Clinical Trials Must Embrace Digital Innovation

Nostalgia can trick us into thinking that things were better in the “good old days”. But the world of science is rarely a place where sentimentality should cloud better judgement. Rather, it is a place where questions, analysis and evidence … Read More

Data Science and Medication Adherence

Examining the Role of Data Science in Understanding Patient Behaviors.

Our latest article in Applied Clinical Trials Online discusses the Role of Data Science and Understanding Patient Behavior. … Read More

Our latest article in PMPS discusses how non-adherence to medication has been costing lives and money for decades but SmartPackaging solutions are now solving the age-old problem.

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2021, pages 46-49. © Samedan Ltd

AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.

AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems … Read More

How digital medication adherence monitoring increases the impact of innovative adherence research?

MEMS® has been a part of successful adherence research for more than 30 years.Download this adherence compendium and find out how digital medication adherence monitoring increases the impact of academic research findings.

AARDEX Group announces the opening of a new office in the U.S.

By establishing itself in the U.S., the Group aims to strengthen its business and maintain its position as market leader in digital adherence monitoring systems. Joe Keenan will lead the business development for the pharma and biotech industry in North America. … Read More

Using data science to detect key changes in medication intake behaviors.

Electronic monitoring, a digital technology based on smart packages, enables the most objective and precise adherence monitoring. By using an evidence-based digital adherence monitoring system, Sponsors and HCPs improve drug efficacy by managing patient adherence to the medications. In this … Read More

How smart packages enable digital medication adherence monitoring for successful clinical trials?

50 % of patients involved in clinical trials do not take their medication as prescribed, resulting in underestimated drug efficacy and delayed approval of the investigational product. Poor medication adherence is thus a threat to drug development. Stop using unreliable … Read More